Bioforce Nanosciences Holdings, Inc.
BFNH- Exchange
- OTC
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001310488
In the last 90 days, Bioforce Nanosciences Holdings, Inc. insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Bioforce Nanosciences Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $400.5K in total
- Insiders trading
- 1
- Net value
- −$400.5K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Bioforce Nanosciences Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ferguson Merle | Director | 0 | Sep 2, 2026 | 1 |
| Kaiser Richard Kaiser | CEO & CFO | 1,234,447 | Sep 2, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)4:09 PM ET | Apr 22 | 133 daysLate | Ferguson MerleDirector | SSaleCommon Stock; Par Value $0.001 | −26.7M | $0.015 | −$400.5K | −100.0%0 after |